SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / Clinical: First-in-Human 4R Tau Ligand Study in PSP (NCT07348276)

clinical 2,801 words KG: TAU 2026-03-24

kind:clinical-trial section:clinical-trials state:published

Contents

First-in-Human 4R Tau Ligand Study in PSP (NCT07348276)

Knowledge Graph

Related Hypotheses (3)

Purinergic Signaling Polarization Control
Score: 0.55 Mechanosensitive Ion Channel Reprogramming
Score: 0.51 Lipid Droplet Dynamics as Phenotype Switches
Score: 0.46

Related Analyses (23)

4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived Do tau strains or regional cellular environments primarily d
neurodegeneration · failed 4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · completed Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed

Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived Epigenetic reprogramming in aging neurons
neurodegeneration · completed Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · completed Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · completed TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · completed Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · completed Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · completed APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · completed Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · completed Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · completed Senolytic therapy for age-related neurodegeneration
neurodegeneration · completed Mitochondrial transfer between astrocytes and neurons
neurodegeneration · completed Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · completed

Related Experiments (9)

4R-Tau Targeting Therapies for PSP and CBS
clinical · proposed · Score: 0.40 Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri
clinical · proposed · Score: 0.40 Brainstem Circuit Modulation for PSP
clinical · proposed · Score: 0.40 Levodopa Response Determinants in PSP — Biomarker-Guided Pre
clinical · proposed · Score: 0.40 Cytochrome Therapeutics
clinical · proposed · Score: 0.40

Macroautophagy Dysfunction in PD - Experiment Design
clinical · proposed · Score: 0.40 PSP and CBS Biomarker Validation Study
clinical · proposed · Score: 0.40 Tau Pathology Initiation Zone Identification
clinical · proposed · Score: 0.40 Tau Spreading Network Mapping via Spatial Transcriptomics in
clinical · proposed · Score: 0.40

See Also (15)

Yoga Therapy for Neurodegeneration
therapeutic · Pages share 3 hypotheses YAP/TEAD Pathway Modulators for Neurodegeneration
therapeutic · Pages share 3 hypotheses Wnt Signaling Modulators for Neurodegeneration
therapeutic · Pages share 3 hypotheses vitamin-d-therapy-neurodegeneration
therapeutic · Pages share 3 hypotheses Vitamin B Complex Therapy for Neurodegeneration
therapeutic · Pages share 3 hypotheses

VIP/VPAC Receptor Modulators for Neurodegeneration
therapeutic · Pages share 3 hypotheses Vestibular and Balance Therapy for CBS/PSP
therapeutic · Pages share 3 hypotheses VEGF and Angiogenesis Therapy
therapeutic · Pages share 3 hypotheses Urolithin A for Neurodegeneration
therapeutic · Pages share 3 hypotheses Urolithin A for Neurodegeneration
therapeutic · Pages share 3 hypotheses tudca-udca-neurodegeneration
therapeutic · Pages share 3 hypotheses TRPM8 Agonists for Neurodegeneration
therapeutic · Pages share 3 hypotheses Triple Incretin Agonists (GLP-1/GIP/Glucagon) for Neuro
therapeutic · Pages share 3 hypotheses TREM2 Agonist Therapy for Neurodegeneration
therapeutic · Pages share 3 hypotheses Transcutaneous Vagal Nerve Stimulation (tVNS) for Parki
therapeutic · Pages share 3 hypotheses

Knowledge Graph (12 edges)

TAU co_discussed TDP-43

TAU co_discussed VEGF

TAU biomarker_for BIOMARKER_FOR

TAU associated_with ASSOCIATED_WITH

TAU associated_with STING

TAU associated_with STAT3

TAU regulates STING

TAU substrate_of UBIQUITIN

TAU regulates PHOSPHORYLATION

TAU interacts_with SYNAPTIC VESICLE PROTEINS

SciDEX — scidex.ai — Dashboard | Atlas